Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...
Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...
An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...
Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools ...
"This next phase of research is crucial to understanding the full potential of vancomycin in PSC-IBD treatment." ...
A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...
The mystery of why people with Inflammatory Bowel Disease (IBD) have a four times higher risk of getting life threatening ...